I am passionate about supporting client innovation and protecting their intellectual property through strategic patent prosecution.
Dr. Jasmine Clark leverages her previous expertise in molecular and cancer biology, neuro-oncology, and small molecule drug delivery to drive patent prosecution in the life sciences industry.
Prior to joining Foley Hoag, Jasmine earned her Ph.D. in Molecular Pharmacology and Physiology at Brown University. Her dissertation explored the pharmacological inhibition of GSK-3 as a novel therapeutic strategy for treatment of pediatric diffuse midline glioma (DMG).
Brown University, Ph.D., Molecular Pharmacology and Physiology, 2026
Old Dominion University, B.S., Chemistry, 2020
Publications
Clark, J.S., Brown University Ph.D. Dissertation, 2026- Breaking Barriers: Evaluating GSK-3 Inhibition as a Dual Therapeutic Strategy in Diffuse Midline Glioma Models.
Jimenez-Macias, J.L., Vaughn-Beaucaire, P., Yan, J., Clark, J., et al., Molecular Cancer Research, 2026 — Decoding the Biology of the Blood-Brain Tumor Barrier in Brain Cancer.
Jimenez-Macias, J.L., Vaughn-Beaucaire, P., Bharati, A., Xu, Z., Forrest, M., Hong, J., Sun, M., Schmidt, A., Clark, J., et al., Science Advances, 2025 — Modulation of blood-tumor barrier transcriptional programs improves intratumoral drug delivery and potentiates chemotherapy in GBM.
Beebe, S.J., Celestine, M.J., Bullock, J.L., Sandhaus, S., Arca, J.F., Cropek, D.M., Ludvig, T.A., Foster, S.R., Clark, J.S., et al., Journal of Inorganic Biochemistry, 2020 — Synthesis, characterization, DNA binding, topoisomerase inhibition, and apoptosis induction studies of a novel cobalt(III) complex with a thiosemicarbazone ligand.
We use cookies to enhance user experience, improve functionality and performance, and for analysis of website traffic. By clicking “accept”, you agree to the use of cookies. For more information about our cookie policy and the information we collect, please review our Privacy Statement.
Foley Hoag
Email Disclaimer
Transmitting information to us by e-mail unilaterally does not establish an attorney-client relationship or impose an obligation on either the law firm or even the receiving lawyer to keep the transmitted information confidential. By clicking "OK," you acknowledge that we have no obligation to maintain the confidentiality of any information you submit to us unless we already represent you or unless we have agreed to receive limited confidential material/information from you as a prospective client. Thus, if you are not a client or someone we have agreed to consider as a prospective client, information you submit to us by e-mail may be disclosed to others or used against you.
If you would like to discuss becoming a client, please contact one of our attorneys to arrange for a meeting or telephone conference. If you wish to disclose confidential information to a lawyer in the firm before an attorney-client relationship is established, the protections that the law firm will provide to such information from a prospective client should be discussed before such information is submitted. Thank you for your interest in Foley Hoag.
